Heterocyclic modulators of HIF activity for treatment of disease
US10208059B2 · kind B2 · utility
1Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2016 |
| Grant date | Feb 19, 2019 |
| Priority date | — |
| Expiry date | Oct 4, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.